Guru’s Opinion on Tonix Pharmaceuticals Holding Corp. [TNXP]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNXP shares is $2.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNXP stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Tonix Pharmaceuticals Holding Corp. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 18, 2019. The new note on the price target was released on August 18, 2017, representing the official price target for Tonix Pharmaceuticals Holding Corp. stock. On February 17, 2016, analysts decreased their price target for TNXP shares from 18 to 10.
The Average True Range (ATR) for Tonix Pharmaceuticals Holding Corp. is set at 0.19 The Price to Book ratio for the last quarter was 0.07, with the Price to Cash per share for the same quarter was set at 0.18.
TNXP Stock Performance Analysis: Tonix Pharmaceuticals Holding Corp. [TNXP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -36.23. With this latest performance, TNXP shares gained by 23.26% in over the last four-week period, additionally sinking by -89.55% over the last 6 months – not to mention a drop of -97.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNXP stock in for the last two-week period is set at 40.33, with the RSI for the last a single of trading hit 36.82, and the three-weeks RSI is set at 42.00 for Tonix Pharmaceuticals Holding Corp. [TNXP]. The present Moving Average for the last 50 days of trading for this stock 1.0600, while it was recorded at 0.6100 for the last single week of trading, and 4.4400 for the last 200 days.
Insight into Tonix Pharmaceuticals Holding Corp. Fundamentals: Return on Total Capital for TNXP is now -109.04, given the latest momentum, and Return on Invested Capital for the company is -108.07. Return on Equity for this stock declined to -108.07, with Return on Assets sitting at -98.31.
Reflecting on the efficiency of the workforce at the company, Tonix Pharmaceuticals Holding Corp. [TNXP] managed to generate an average of -$2,174,083 per employee.Tonix Pharmaceuticals Holding Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.90 and a Current Ratio set at 4.90.
Market Data 
Markets 
AI
